Format

Send to

Choose Destination
JAMA Intern Med. 2016 Mar;176(3):300-1. doi: 10.1001/jamainternmed.2015.8320.

Intensive Glycemic Control in Type 2 Diabetes Mellitus -- A Balancing Act of Latent Benefit and Avoidable Harm: A Teachable Moment.

Author information

1
Knowledge and Evaluation Research Unit, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, Minnesota2Endocrinology Division, Department of Internal Medicine, University Hospital "Dr Jose E. Gonza.
2
Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
3
Division of Primary Care Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota5Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
PMID:
26882223
PMCID:
PMC5050553
DOI:
10.1001/jamainternmed.2015.8320
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center